The US Consumer Product Safety Commission has issued a recall for the Nvidia Shield 8″ tablet.
WASHINGTON, July 31, 2015 /PRNewswire-USNewswire/ — http://www.cpsc.gov/en/Recalls/2015/NVIDIA-Recalls-Tablet-Computers/
The U.S. Consumer Product Safety Commission is an independent federal agency created by Congress in 1973 and charged with protecting the American public from unreasonable risks of serious injury or death from more than 15,000 types of consumer products under the agency’s jurisdiction. To report a dangerous product or a product-related injury, call the CPSC hotline at 1-800-638-2772, or visit http//:www.cpsc.gov/talk.html. Further recall information is available at http://www.cpsc.gov.
Recall Summary
Name of Product: NVIDIA SHIELD tablet computers
Hazard: The lithium-ion battery in the tablets can overheat, posing a fire hazard.
Remedy: Replace
Consumers should immediately stop using the tablets and contact NVIDIA for instructions on receiving a free replacement tablet.
Consumer Contact: NVIDIA toll free at (888) 943-4196 from 8 a.m. to 5 p.m. PT Monday through Friday or online at www.nvidia.com and click on “NVIDIA Tablet Recall Program” at the bottom center of the page in green letters.
Recall Details
Units: About 83,000 (in addition, 5,000 were sold in Canada)
Description: This recall involves NVIDIA SHIELD tablet computers with 8-inch touch screens. Model numbers P1761, P1761W and P1761WX and serial numbers 0410215901781 through 0425214604018 are included in this recall. NVIDIA and the model and serial numbers are etched on the left side edge of the tablets. The SHIELD logo is on the back of the tablets.
Incidents/Injuries: NVIDIA has received four reports of batteries overheating due to thermal runaway, including two reports of damage to flooring.
Sold at: GameStop stores nationwide and online at Amazon.com, BestBuy.com, GameStop.com, NewEgg.com, TigerDirect.com and other websites from July 2014 through July 2015 for between $300 and $400.
Importer: NVIDIA Corp., of Santa Clara, Calif.
Manufactured in: China
Note: Health Canada’s press release is available at http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/54452r-eng.php
